These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34193193)

  • 41. Acetylcholine receptor antibody in the diagnosis of myasthenia gravis.
    Nicholson GA; McLeod JG; Griffiths LR
    Med J Aust; 1983 Oct; 2(7):334-7. PubMed ID: 6621466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.
    Mantegazza R; Wolfe GI; Muppidi S; Wiendl H; Fujita KP; O'Brien FL; Booth HDE; Howard JF;
    Neurology; 2021 Jan; 96(4):e610-e618. PubMed ID: 33229455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
    Howard JF; Bril V; Burns TM; Mantegazza R; Bilinska M; Szczudlik A; Beydoun S; Garrido FJRR; Piehl F; Rottoli M; Van Damme P; Vu T; Evoli A; Freimer M; Mozaffar T; Ward ES; Dreier T; Ulrichts P; Verschueren K; Guglietta A; de Haard H; Leupin N; Verschuuren JJGM;
    Neurology; 2019 Jun; 92(23):e2661-e2673. PubMed ID: 31118245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis.
    Wang ZY; Okita DK; Howard J; Conti-Fine BM
    Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ravulizumab use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.
    Katyal N; Govindarajan R; Goyal N; Muley S; Muppidi S
    Front Neurol; 2024; 15():1378080. PubMed ID: 38919970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful Transition from Plasma Exchange to Eculizumab in Acetylcholine Receptor Antibody- and Muscle-Specific Kinase (MuSK) Antibody-Negative Myasthenia Gravis: A Case Report.
    Greenwood GT; Lynch Z
    Am J Case Rep; 2020 May; 21():e921431. PubMed ID: 32417849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis.
    Zhang Y; Jia X; Xia Y; Li H; Chen F; Zhu J; Zhang X; Zhang Y; Wang Y; Xu Y; Pan M; Huang X; Yu T; Fu L; Xiao C; Geng D
    Autoimmunity; 2018 May; 51(3):126-134. PubMed ID: 29569949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
    Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
    Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myasthenia gravis with anti-acetylcholine receptor antibodies.
    Meriggioli MN
    Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes and prognostic factors in generalized myasthenia gravis.
    Ozawa Y; Uzawa A; Yasuda M; Kojima Y; Onishi Y; Oda F; Kanai T; Himuro K; Kawaguchi N; Kuwabara S
    J Neurol; 2021 Oct; 268(10):3781-3788. PubMed ID: 33774750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis.
    Yin W; Allman W; Ouyang S; Li Y; Li J; Christadoss P; Yang H
    J Neuroimmunol; 2013 Mar; 256(1-2):49-54. PubMed ID: 23266128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generalization of ocular myasthenia gravis 10 years after onset.
    Guéguen A; Hijazi B; Zuber K; Deschamps R; Lamirel C; Vignal-Clermont C; Gout O
    J Neurol; 2022 Dec; 269(12):6597-6604. PubMed ID: 36001142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FoxP3
    Meng H; Zheng S; Zhou Q; Gao Y; Ni Y; Liang H; Chen S
    Front Neurol; 2021; 12():755356. PubMed ID: 34975721
    [No Abstract]   [Full Text] [Related]  

  • 54. A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.
    Yin J; Zhao M; Xu X; Zhang M; Xu Z; Li Z; Qin X; Li Z; Zhao C; Zhou H; Ma Y; Cao W; Wang G; Lin Y; Zhang J; Zhang X; Cai H; Qian W; Wang Y; Zhang X; Liu G; Wang J; Qiu W; Min L; Li J; Deng H; Chu L; Zhang Y; Fang J
    Eur J Neurol; 2024 Aug; 31(8):e16322. PubMed ID: 38726639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis.
    Mee J; Paine M; Byrne E; King J; Reardon K; O'Day J
    J Neuroophthalmol; 2003 Dec; 23(4):251-5. PubMed ID: 14663303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different characteristics of nonthymomatous generalized myasthenia gravis with and without oropharyngeal involvement.
    Yu L; Li J; Ma S; Jiang J; Wang T; Gamliel Z; Jing Y; Zhang X; Krasna MJ
    Ann Thorac Surg; 2007 Nov; 84(5):1694-8. PubMed ID: 17954087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ocular Myasthenia Gravis: Toward a Risk of Generalization Score and Sample Size Calculation for a Randomized Controlled Trial of Disease Modification.
    Wong SH; Petrie A; Plant GT
    J Neuroophthalmol; 2016 Sep; 36(3):252-8. PubMed ID: 27031125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.